Evidence map›Paper›PMID 42803827›Full record

ArticleJournal of neurology2026

Progressive motor impairment from intracerebral critical demyelinating lesions.

Purnashree Chowdhury, Eoin P Flanagan, Yong Guo, W Oliver Tobin, Bianca Albites Coen, Claudia F Lucchinetti, Brian G Weinshenker, Orhun H Kantarci, B Mark Keegan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Purnashree ChowdhuryDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Eoin P FlanaganDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Yong GuoDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
W Oliver TobinDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Bianca Albites CoenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Claudia F LucchinettiDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Brian G WeinshenkerDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Orhun H KantarciDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
B Mark KeeganDepartment of Neurology, Mayo Clinic, Rochester, MN, USA. keegan.bmark@mayo.edu.ORCID http://orcid.org/0000-0002-2880-935X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFocal critical demyelinating lesions anatomically associated with progressive motor impairment are described in multiple sclerosis (MS) and restricted demyelinating diseases, typically within the spinal cord lateral column and ventral cervicomedullary junction (CMJ). This study describes such lesions within the intracerebral corticospinal tracts.

methodsWe retrospectively reviewed people seen at Mayo MS Clinic (2002-2025) with progressive central nervous system demyelinating disease and progressive (≥ 1 year) upper motor neuron weakness anatomically associated with a presumed demyelinating lesion of the cerebral white matter, internal capsule, or upper brainstem, excluding alternative spinal cord or CMJ lesions. Demographics, disease course, Expanded Disability Status Scale (EDSS), MS disease-modifying therapy use, brain and spinal cord magnetic resonance imaging, cerebrospinal fluid studies and neuropathology findings were reviewed.

resultsSeventeen people had an intracerebral critical demyelinating lesion: cerebral white matter in 12 (70%), internal capsule in 3 (18%) and upper brainstem in 2 (12%). Ten were female, and all were white. Progression from onset course was 13 (76%) and from relapse onset was 4 (24%). Median, interquartile range (IQR) for age at progressive motor impairment onset was 46 (IQR 38-52) years, and EDSS at last evaluation was 5.5 (IQR 4.0-5.5). Sixteen (94%) had progressive spastic hemiparesis and 1 (6%) monoparesis. Cognitive impairment occurred in 6/12 (50%) and seizures in 3/12 (25%) with cerebral white matter critical lesions. Abnormal intrathecal production of immunoglobulin G markers was consistent with MS in 10/15 (66%). Neuropathology confirmed demyelination in 4/6 biopsies.

conclusionsIntracerebral critical demyelinating lesions associated with progressive motor impairment can rarely occur along the corticospinal tracts of the brain.

Indexed as

Brain StemDemyelinating DiseasesInternal CapsulePyramidal TractsWhite MatterAdultDisease ProgressionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesCervicomedullary junctionCritical lesionDemyelinating diseaseIntracerebralMotor impairmentMultiple sclerosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.